General Pharmacology Practice Questions

Q: Which of the following is a prodrug?

Levodopa. **Explanation:** A **prodrug** is a pharmacologically inactive compound that must undergo metabolic conversion (usually in the liver or target tissues) to become an active drug. **Why Levodopa is correct:** Levodopa is the classic example of a prodrug used in Parkinsonism. It is an amino acid precursor of dopamine. While dopamine itself cannot cross the blood-brain barrier (BBB), Levodopa crosses the BBB via large neutral amino acid transporters. Once inside the CNS, it is decarboxylated by the enzyme **Dopa-decarboxylase** into its active form, **Dopamine**, which then acts on striatal receptors. **Why the other options are incorrect:** * **Pioglitazone:** This is an active Thiazolidinedione used in Type 2 Diabetes. It acts directly on PPAR-gamma receptors without requiring metabolic activation. * **Dexamethasone:** A potent glucocorticoid that is active in its administered form. (Note: *Prednisone* is a prodrug converted to *Prednisolone*, but Dexamethasone is not). * **Captopril:** Most ACE inhibitors are prodrugs (e.g., Enalapril to Enalaprilat), but **Captopril and Lisinopril** are the two notable exceptions—they are active drugs. **High-Yield Clinical Pearls for NEET-PG:** * **ACE Inhibitor Rule:** All ACE inhibitors are prodrugs except **Captopril** and **Lisinopril**. * **Active Metabolites:** Some drugs are active themselves but also have active metabolites (e.g., Diazepam to Nordiazepam). * **Common Prodrugs Mnemonic (All Prefer Drugs In Clear Liquid Form):** **A**CE inhibitors (most), **P**roguanil, **D**ipivefrin, **I**rinosan, **C**yclophosphamide, **L**evodopa, **F**luorouracil (5-FU).

Q: Which of the following does NOT act as an ionic channel?

Insulin. The core concept here is the classification of cell surface receptors. Receptors are broadly divided into **Ionotropic** (ligand-gated ion channels), **Metabotropic** (G-protein coupled), and **Enzyme-linked** receptors. **Why Insulin is the correct answer:** Insulin does not act via an ionic channel. Instead, it acts through a **Tyrosine Kinase receptor** (an enzyme-linked receptor) [1]. When insulin binds to the alpha subunits of its receptor, it triggers autophosphorylation of the beta subunits, activating a signaling cascade (MAP kinase and PI3K pathways) to regulate glucose uptake and metabolism [1]. **Analysis of incorrect options:** * **Nicotine:** Acts on **Nicotinic Acetylcholine Receptors (nAChR)**, which are classic pentameric ligand-gated **sodium/potassium channels**. Binding leads to rapid depolarization. * **Glibenclamide:** This is a Sulfonylurea that targets the **ATP-sensitive Potassium (K⁺-ATP) channel** in pancreatic beta cells [2]. By closing these channels, it induces depolarization and insulin release. * **Diazepam:** A Benzodiazepine that acts as a positive allosteric modulator of the **GABA-A receptor**, which is a ligand-gated **Chloride (Cl⁻) channel**. It increases the frequency of channel opening, leading to hyperpolarization. **High-Yield Clinical Pearls for NEET-PG:** * **Fastest receptors:** Ionotropic (milliseconds), e.g., GABA-A, nAChR, NMDA. * **Slowest receptors:** Nuclear receptors (hours to days), e.g., Steroids, Thyroid hormone. * **Insulin Receptor Structure:** It is a heterotetramer ($α_2β_2$) linked by disulfide bonds [1]. * **G-Protein Coupled Receptors (GPCR):** The largest family of receptors (e.g., Adrenergic, Muscarinic, Opioid receptors).

Q: All of the following statements about mycophenolate mofetil are true except:

It is highly nephrotoxic. ### Explanation **Mycophenolate Mofetil (MMF)** is a potent immunosuppressant widely used in transplant medicine and autoimmune disorders. The correct answer is **D** because MMF is notably **not nephrotoxic**, which distinguishes it from other major immunosuppressants like Calcineurin Inhibitors (CNIs). #### Why Option D is the Correct Answer (The "Except"): Unlike Cyclosporine and Tacrolimus, which cause significant renal vasoconstriction and chronic interstitial fibrosis [1], MMF does not cause kidney damage. In fact, MMF is often used as a "renal-sparing" agent to allow for a reduction in the dose of nephrotoxic CNIs in transplant recipients. #### Analysis of Other Options: * **Option A (True):** MMF is a **prodrug** that is rapidly hydrolyzed in the liver to its active metabolite, **Mycophenolic Acid (MPA)**. * **Option B (True):** **Gastrointestinal (GI) toxicity** is the most common side effect [1]. Patients frequently experience nausea, vomiting, abdominal pain, and diarrhea. This is often the dose-limiting factor in clinical practice. * **Option C (True):** MMF is highly effective and is used as a first-line or rescue therapy in renal, hepatic, and cardiac transplants to prevent acute rejection, especially when other regimens fail or cause intolerable toxicity. #### NEET-PG High-Yield Pearls: * **Mechanism of Action:** It acts as a reversible inhibitor of **Inosine Monophosphate Dehydrogenase (IMPDH)**. This inhibits the *de novo* synthesis of guanosine nucleotides. * **Selectivity:** T and B lymphocytes are highly dependent on the *de novo* pathway (unlike other cells that use the salvage pathway), making MMF a **selective** lymphocyte inhibitor. * **Side Effects:** Apart from GI distress, it causes **myelosuppression** (neutropenia). * **Teratogenicity:** It is contraindicated in pregnancy (Category D) as it can cause "Mycophenolate Embryopathy" (ear and facial abnormalities).

Q: Which of the following is NOT an accepted use of Cyclosporine?

Multiple myeloma. **Explanation:** **Cyclosporine** is a potent immunosuppressant that acts as a **calcineurin inhibitor**. It binds to cyclophilin, forming a complex that inhibits calcineurin, thereby preventing the dephosphorylation of NFAT (Nuclear Factor of Activated T-cells). This results in the inhibition of IL-2 production and T-cell proliferation. **Why Multiple Myeloma is the Correct Answer:** Multiple myeloma is a **plasma cell malignancy**. The mainstay of treatment involves proteasome inhibitors (Bortezomib), immunomodulators (Lenalidomide), steroids, and alkylating agents. Cyclosporine has no established role in treating plasma cell dyscrasias or hematological malignancies; in fact, long-term immunosuppression with cyclosporine can theoretically increase the risk of secondary lymphomas. **Analysis of Other Options:** * **Organ Transplant:** Cyclosporine revolutionized transplant medicine. It is a first-line agent for preventing graft-versus-host disease (GVHD) and organ rejection in kidney, liver, and heart transplants. * **Rheumatoid Arthritis (RA):** It is used as a Disease-Modifying Antirheumatic Drug (DMARD) in severe, active RA cases that do not respond adequately to methotrexate. * **Recalcitrant Psoriasis:** Due to its T-cell inhibitory action, it is highly effective for severe, plaque-type psoriasis that is resistant to topical therapies or phototherapy. **NEET-PG High-Yield Pearls:** * **Side Effects (Mnemonic: 5 H’s):** **H**irsutism, **H**yperplasia of gums, **H**ypertension, **H**yperlipidemia, and **H**epatotoxicity. * **Nephrotoxicity:** The most common and dose-limiting adverse effect (causes afferent arteriolar vasoconstriction). * **Monitoring:** Requires Therapeutic Drug Monitoring (TDM) due to a narrow therapeutic index. * **Drug Interactions:** Metabolized by CYP3A4; levels increase with Grapefruit juice and Ketoconazole.

Q: Which of the following medications is available as a transdermal patch?

Oxybutynin. **Explanation:** **Oxybutynin** is a competitive muscarinic receptor antagonist used primarily for the treatment of overactive bladder (OAB). It is available in multiple formulations, including oral (immediate and extended-release) and **transdermal patches**. The transdermal route for Oxybutynin is clinically significant because it bypasses **first-pass hepatic metabolism** (specifically the CYP3A4 enzyme in the liver and gut). This significantly reduces the formation of its active metabolite, *N-desethyloxybutynin*, which is primarily responsible for the common anticholinergic side effect of **xerostomia (dry mouth)**. Consequently, the patch offers better patient compliance compared to oral forms. **Analysis of Incorrect Options:** * **Flavoxate:** An antispasmodic used for urinary tract spasms; it is administered only **orally**. * **Tolterodine:** Another common anticholinergic for OAB. While it is available as an extended-release (ER) oral capsule, it does **not** have a transdermal patch formulation. * **Aripiprazole:** An atypical antipsychotic available as oral tablets, disintegrating tablets, and long-acting intramuscular injections, but **not** as a transdermal patch. **High-Yield Clinical Pearls for NEET-PG:** * **Common Transdermal Patches:** Remember the mnemonic **"Fentanyl, Nicotine, Scopolamine, Nitroglycerin, Clonidine, Estrogen, Testosterone, and Oxybutynin."** * **Rivastigmine** (for Alzheimer’s) and **Rotigotine** (for Parkinson’s) are other high-yield CNS drugs available as patches. * **Selegiline** is the only MAO inhibitor available as a transdermal patch (used for MDD).

Q: Which schedule of the Drugs and Cosmetics Act mandates that a drug must be sold by retail only upon production of a prescription from a Registered Medical Practitioner?

Schedule H. ### Explanation **Correct Option: A. Schedule H** The Drugs and Cosmetics Act (1940) and Rules (1945) classify drugs into various schedules to regulate their manufacture, sale, and distribution. **Schedule H** contains a list of "Prescription Drugs." By law, these drugs can only be sold by retail upon the production of a valid prescription from a **Registered Medical Practitioner (RMP)**. The label of these drugs must display the symbol ‘Rx’ and a warning stating that they are not to be sold without a prescription. **Analysis of Incorrect Options:** * **Schedule M:** This schedule specifies the **Good Manufacturing Practices (GMP)** and requirements for factory premises, plants, and equipment for pharmaceutical products. * **Schedule P:** This deals with the **Life period (expiry date)** and storage conditions of various drugs (e.g., Insulin, Antibiotics). * **Schedule W:** This previously listed drugs that were to be marketed under **Generic names** only (though this schedule has largely been omitted/merged in recent amendments). **High-Yield Clinical Pearls for NEET-PG:** * **Schedule H1:** Introduced in 2013 to curb the misuse of antibiotics and anti-TB drugs. It requires the pharmacist to maintain a separate register with patient and prescriber details, retained for 3 years. * **Schedule X:** Includes psychotropic drugs and narcotics (e.g., Ketamine, Amphetamines). These require a double-copy prescription, and the pharmacist must keep one copy for 2 years. * **Schedule G:** Drugs that must be taken under **medical supervision** (e.g., Metformin, Antihistamines) but do not necessarily require a formal prescription for every refill like Schedule H. * **Schedule Y:** Guidelines for **Clinical Trials** and import/manufacture of new drugs.

Q: Which of the following statements is NOT true regarding mycophenolate mofetil?

It is nephrotoxic.. **Explanation:** **Mycophenolate Mofetil (MMF)** is a potent immunosuppressant widely used in transplant medicine. The correct answer is **D** because MMF is notably **not nephrotoxic**, which distinguishes it from calcineurin inhibitors (CNIs) like Cyclosporine and Tacrolimus. 1. **Why Option D is the correct answer:** MMF’s primary advantage in renal transplantation is its lack of nephrotoxicity. Its dose-limiting toxicities are primarily **gastrointestinal** (nausea, vomiting, diarrhea) and **hematological** (leukopenia, anemia). Because it does not damage the kidneys, it is often used to allow for a reduction in the dose of nephrotoxic CNIs. 2. **Analysis of Incorrect Options:** * **Option A:** MMF is indeed a **prodrug** that is rapidly hydrolyzed in the liver to its active metabolite, **mycophenolic acid (MPA)**. * **Option B:** In clinical practice, the "Triple Drug Regimen" for maintenance immunosuppression typically consists of a **CNI** (Tacrolimus/Cyclosporine), an **antimetabolite** (MMF), and a **glucocorticoid** (Prednisolone). * **Option C:** MMF and Azathioprine are both antimetabolites that inhibit purine synthesis. Using them together increases the risk of severe bone marrow suppression without added benefit; therefore, they are **not** used concurrently. **High-Yield Clinical Pearls for NEET-PG:** * **Mechanism of Action:** Potent, reversible, non-competitive inhibitor of **Inosine Monophosphate Dehydrogenase (IMPDH)**. This inhibits the *de novo* pathway of guanosine nucleotide synthesis. * **Selectivity:** T and B lymphocytes are highly dependent on the *de novo* pathway (unlike other cells which use the salvage pathway), making MMF a selective lymphocyte inhibitor. * **Teratogenicity:** MMF is associated with "Mycophenolate Embryopathy" (ear and facial abnormalities) and is contraindicated in pregnancy.

Q: All of the following can cause histamine release except?

Propranolol. **Explanation:** The question tests your knowledge of drugs that cause **non-immunological (direct) histamine release** from mast cells. **1. Why Propranolol is the Correct Answer:** Propranolol is a non-selective beta-blocker. It does not possess the chemical structure or pharmacological property to trigger direct histamine release. In fact, in the context of allergy, beta-blockers are significant because they can **worsen** anaphylaxis and make it resistant to adrenaline, but they do not cause histamine release themselves. **2. Analysis of Incorrect Options:** * **D-tubocurarine:** This skeletal muscle relaxant is a classic example of a drug that causes direct histamine release, often leading to hypotension, flushing, and bronchospasm [1]. * **Morphine:** Opioids (especially morphine and codeine) trigger mast cell degranulation via a non-IgE mediated pathway [1]. This often results in "morphine itch" (pruritus) or urticaria. * **Vancomycin:** This antibiotic is notorious for causing **"Red Man Syndrome"** (or Red Neck Syndrome). This is a rate-dependent infusion reaction caused by direct histamine release, characterized by intense flushing of the upper body. **3. NEET-PG High-Yield Clinical Pearls:** * **Direct Histamine Releasers (Mnemonic: "M-A-V-E-D"):** **M**orphine, **A**mphotericin B, **V**ancomycin, **E**pinephrine (rarely), **D**-tubocurarine/Radiocontrast media [1]. * **Red Man Syndrome Prevention:** Slow the infusion rate of Vancomycin (administer over at least 60 minutes) and/or pre-treat with antihistamines. * **Clinical Sign:** Direct histamine release usually causes localized or systemic flushing, hypotension, and pruritus, but unlike true Type I hypersensitivity, it is not IgE-mediated and often depends on the dose or rate of administration [1].

Question 1

Which of the following is a prodrug?

Accepted Answer

Levodopa

Answer

Pioglitazone

Answer

Dexamethasone

Answer

Captopril

Question 2

All the following drugs are inducers of cytochrome P450 enzymes except?

Accepted Answer

Ketoconazole

Answer

Ritonavir

Answer

Chloral hydrate

Answer

Isoniazid

Question 3

Which of the following does NOT act as an ionic channel?

Accepted Answer

Insulin

Answer

Nicotine

Answer

Glibenclamide

Answer

Diazepam

Question 4

All of the following statements about mycophenolate mofetil are true except:

Accepted Answer

It is highly nephrotoxic

Answer

It is a prodrug

Answer

Gastrointestinal toxicity is common

Answer

It is used in transplant recipients where other drugs are not effective

Question 5

Which of the following is NOT an accepted use of Cyclosporine?

Accepted Answer

Multiple myeloma

Answer

Organ transplant

Answer

Rheumatoid arthritis

Answer

Recalcitrant psoriasis

Question 6

Which of the following medications is available as a transdermal patch?

Accepted Answer

Oxybutynin

Answer

Flavoxate

Answer

Tolterodine

Answer

Aripiprazole

Question 7

Which schedule of the Drugs and Cosmetics Act mandates that a drug must be sold by retail only upon production of a prescription from a Registered Medical Practitioner?

Accepted Answer

Schedule H

Answer

Schedule M

Answer

Schedule P

Answer

Schedule W

Question 8

Which of the following statements is NOT true regarding mycophenolate mofetil?

Accepted Answer

It is nephrotoxic.

Answer

It is a prodrug of mycophenolic acid.

Answer

It can be used concurrently with a calcineurin inhibitor and a glucocorticoid.

Answer

It cannot be used concurrently with azathioprine.

Question 9

Therapeutic drug monitoring is not indicated for which of the following medications?

Accepted Answer

Propranolol

Answer

Phenytoin

Answer

Piroxicam

Answer

Prazosin

Question 10

All of the following can cause histamine release except?

Accepted Answer

Propranolol

Answer

D-tubocurarine

Answer

Morphine

Answer

Vancomycin

General Pharmacology — MCQs

General Pharmacology — MCQs

On this page

Practice by Chapter

Want unlimited practice?